TABLE 1.

Demographic and clinical characteristics of all subjects.

	WD patients (N = 17)	HC (N = 20)
Gender (male/female)	10/7	12/8
Age (years)*	32.23(7.55)	30.4 (7.59)
Disease duration (years)	10.83(6.74)	–
Treatment duration (years)	8.15 (6.07)	–
Kayser-Fleischer rings	16/17	–
Serum ceruloplasmin (<0.15 g/L)	17/17	–
UWDRS neurological subscores	13.71(12.14)	–
T2/FLAIR hyperintensities	15/17	0/20
Brian atrophy	11/17	0/20

Standard deviations are in parentheses. *P = 0.478; Mann-Whitney U test was used for age comparison. Normal reference range: serum ceruloplasmin, 0.2–0.45 g/L. FLAIR, fluid-attenuated inversion recovery; HC, healthy controls; N, number; UWDRS, Unified Wilson’s Disease Rating Scale; WD, Wilson’s disease.